ELTP Discussion 08/16/2014 13:27:19 $ELTP
Yeah we'll Buffet never found a co with 15 hammerlocked ART patents! Booya
“Be Fearful When Others Are Greedy and Greedy When Others Are Fearful”
Quote:
Buffet has never invested in a company that was losing money.
within 18 months when ELI200 in on the market and ELTP has there plugg and play tech to extend the pipeline with 15 more ART products,ELITE could easily be a profitable company trading at 5 dollar on nasdaq and so be a new playground for whales like Buffet,right??
Quote:
Benjamin and Graham would not consider investing in a company like ELTP--not until the management was proven
would the launch of ELI200 be proof for Benjamin and Graham that management did the job they supposed to do??
More risk = More reward.
My ENTIRE NET WORTH is in this and I am NEVER SELLING - "Our favorite holding period is forever."
ELTP is NOT losing money. They are spending their money on R and D for products worth BILLIONS of dollars.
Nasrat WILL NOT be stopped - "Nobody can stop us."
When ELTP gets bought out for $3.60 and I make 5 MILLION dollars don't come asking me for a loan.
Excellent idea. Maybe Elite can dedicate part of the 20,000sf for marijuana abstracts, spirits, and capsules for sale in States where authorized. No that would cause ELTP to hit the high ropes! OR would it not?
I understand we had an agreement with Epic for 8 drugs where we get a 15% profit split. I also understand that we are no longer proceeding with the last 7 drugs. However, the first and only drug has been filed with the FDA for 3 1/2 years now and we haven't heard anything. Do you have any updates on this?
Issue a prescription for the Embeda with no substitute authorized and see what happens. Understand doctors can do that.
Warren Buffet would not even LOOK at ELTP. LOL
Buffet has never invested in a company that was losing money. Benjamin and Graham would not consider investing in a company like ELTP--not until the management was proven and cash flow positive.
Nasrat is a talented CEO--but he is not God yet.
Thank you for the chuckle. Always good to have a belly laugh now and then.
Yes it does make it so. Nobody can stop us and we are going to the anti-abuse land.
Quote:
Just because a CEO declares. "No one can stop us!" or something like that does not make it so. It means ONE person--the CEO--has that opinion.
Warren Buffett couldn't care less about the technicals. I will follow him and buy all I can in undervalued companies and never sell. He's only worth around 60 billion. I'll take his advice.
I've been telling you about the buyout for years now. I've also been telling you I am never selling and I am waiting for the buyout so I get the max PPS. People are finally coming around and admitting I was right all along.
Quote:
Product is modular so you are looking at a several billion dollar buyout. This is the most likely end game with Elite. Just a matter of when it happens. The further along this goes, the higher the price goes.
Here is what is hysterically funny....the question was how did second quarter launch of Embeda go? It's a month and a half into Q3, any signs of Embeda yet? Lolzzz
Here is what is hysterically funny: the study being commented on was not of embeda
Bwaaaaaaaaaaaaaaaaaaaaa
lol lol
**** Elite Pharmaceuticals Conference Call Questions ****
Shareholders participating in the Conference Call are typically allowed to ask 1 or 2 questions following the company's prepared statements.
To make the most of this Q&A opportunity with ELTP management, suggest that we come up with a list to share of top questions to ask:
(Copy/paste and add your question(s) at the end of the latest posted list)
1. Clinical Trials
a. When can we expect Lifetree abuse liability results?
b. How long do you expect these trials to last?
c. How many products are tested at a time in these studies?
d. Is the plan to file upon successful results?
2. Please explain the purpose for the upcoming meeting in October with the FDA. Best case and worst case scenario.
3. With so much going on will Analyst be reassess-updating last Falls value of Elite for future negotiations?
6. Lincoln Park Capital (LPC) Securities Funding
a. How many have been placed with LPC exclusive of the free shares?
b. How much money was generated for the shares?
c. How much of the money has been spent?
d. What was it used on?
7. 2 FDA applications ... what info can we get? How long have they been in the system?
8. 11 ANDA's for site transfer, what's going on?
9. Any plans for Eli-154?
10. What's the next step for Eli-201?
11. What's going on with the three drugs in Scale up?
12. Any generics moving up the ladder to commercialization?
13. Given the share price hovering at the “worst case” scenario, and far below the 2.10-2.75 levels that were indicated
as the more reasonable valuation range at that time, why are you comfortable with the valuation as reflective of Elite’s future?
14. In July, the FDA approved Purdue's Targiniq ER with labeling describing the product's abuse-deterrent properties. Is ELTP's ART more effective than Purdue's? If so, is it likely that the FDA will also approve ELTP's ART products?
15. What is ELTP expecting from the FDA by filing the INDs for ELI-200 and ELI-202?
16. Given the information in the 10-Q regarding the expansion of the Northvale facilities... Does this mean ELTP could potentially manufacture and distribute all of the ART drugs without a partner?
Excuses excuses. ...anybody know if Embeda launched Q2 like they stated they would????
Lolzzz
Misleading information from one open label study .
Let's give them "medical marijuana"!
Yeah, that's the ticket!
6 out of 10 said it's not the answer. Elite has superior technology and will release multiple ADT products onto the market!
Universally? Guess it is predictable then or a minimum predictability is in question which is unpredictable.
Yeah we'll Buffet never found a co with 15 hammerlocked ART patents! Booya
“Be Fearful When Others Are Greedy and Greedy When Others Are Fearful”
Quote:
Buffet has never invested in a company that was losing money.
within 18 months when ELI200 in on the market and ELTP has there plugg and play tech to extend the pipeline with 15 more ART products,ELITE could easily be a profitable company trading at 5 dollar on nasdaq and so be a new playground for whales like Buffet,right??
Quote:
Benjamin and Graham would not consider investing in a company like ELTP--not until the management was proven
would the launch of ELI200 be proof for Benjamin and Graham that management did the job they supposed to do??
More risk = More reward.
My ENTIRE NET WORTH is in this and I am NEVER SELLING - "Our favorite holding period is forever."
ELTP is NOT losing money. They are spending their money on R and D for products worth BILLIONS of dollars.
Nasrat WILL NOT be stopped - "Nobody can stop us."
When ELTP gets bought out for $3.60 and I make 5 MILLION dollars don't come asking me for a loan.
Excellent idea. Maybe Elite can dedicate part of the 20,000sf for marijuana abstracts, spirits, and capsules for sale in States where authorized. No that would cause ELTP to hit the high ropes! OR would it not?
I understand we had an agreement with Epic for 8 drugs where we get a 15% profit split. I also understand that we are no longer proceeding with the last 7 drugs. However, the first and only drug has been filed with the FDA for 3 1/2 years now and we haven't heard anything. Do you have any updates on this?
Issue a prescription for the Embeda with no substitute authorized and see what happens. Understand doctors can do that.
Warren Buffet would not even LOOK at ELTP. LOL
Buffet has never invested in a company that was losing money. Benjamin and Graham would not consider investing in a company like ELTP--not until the management was proven and cash flow positive.
Nasrat is a talented CEO--but he is not God yet.
Thank you for the chuckle. Always good to have a belly laugh now and then.
Yes it does make it so. Nobody can stop us and we are going to the anti-abuse land.
Quote:
Just because a CEO declares. "No one can stop us!" or something like that does not make it so. It means ONE person--the CEO--has that opinion.
Warren Buffett couldn't care less about the technicals. I will follow him and buy all I can in undervalued companies and never sell. He's only worth around 60 billion. I'll take his advice.
I've been telling you about the buyout for years now. I've also been telling you I am never selling and I am waiting for the buyout so I get the max PPS. People are finally coming around and admitting I was right all along.
Quote:
Product is modular so you are looking at a several billion dollar buyout. This is the most likely end game with Elite. Just a matter of when it happens. The further along this goes, the higher the price goes.
Here is what is hysterically funny....the question was how did second quarter launch of Embeda go? It's a month and a half into Q3, any signs of Embeda yet? Lolzzz
Here is what is hysterically funny: the study being commented on was not of embeda
Bwaaaaaaaaaaaaaaaaaaaaa
lol lol
**** Elite Pharmaceuticals Conference Call Questions ****
Shareholders participating in the Conference Call are typically allowed to ask 1 or 2 questions following the company's prepared statements.
To make the most of this Q&A opportunity with ELTP management, suggest that we come up with a list to share of top questions to ask:
(Copy/paste and add your question(s) at the end of the latest posted list)
1. Clinical Trials
a. When can we expect Lifetree abuse liability results?
b. How long do you expect these trials to last?
c. How many products are tested at a time in these studies?
d. Is the plan to file upon successful results?
2. Please explain the purpose for the upcoming meeting in October with the FDA. Best case and worst case scenario.
3. With so much going on will Analyst be reassess-updating last Falls value of Elite for future negotiations?
6. Lincoln Park Capital (LPC) Securities Funding
a. How many have been placed with LPC exclusive of the free shares?
b. How much money was generated for the shares?
c. How much of the money has been spent?
d. What was it used on?
7. 2 FDA applications ... what info can we get? How long have they been in the system?
8. 11 ANDA's for site transfer, what's going on?
9. Any plans for Eli-154?
10. What's the next step for Eli-201?
11. What's going on with the three drugs in Scale up?
12. Any generics moving up the ladder to commercialization?
13. Given the share price hovering at the “worst case” scenario, and far below the 2.10-2.75 levels that were indicated
as the more reasonable valuation range at that time, why are you comfortable with the valuation as reflective of Elite’s future?
14. In July, the FDA approved Purdue's Targiniq ER with labeling describing the product's abuse-deterrent properties. Is ELTP's ART more effective than Purdue's? If so, is it likely that the FDA will also approve ELTP's ART products?
15. What is ELTP expecting from the FDA by filing the INDs for ELI-200 and ELI-202?
16. Given the information in the 10-Q regarding the expansion of the Northvale facilities... Does this mean ELTP could potentially manufacture and distribute all of the ART drugs without a partner?
Excuses excuses. ...anybody know if Embeda launched Q2 like they stated they would????
Lolzzz
Misleading information from one open label study .
Let's give them "medical marijuana"!
Yeah, that's the ticket!
6 out of 10 said it's not the answer. Elite has superior technology and will release multiple ADT products onto the market!
Universally? Guess it is predictable then or a minimum predictability is in question which is unpredictable.
